Furthermore, ACE2 overexpression decreased myocardium AngII levels, increased myocardium Ang (1–7) levels, and reduced ACE expression in the rat model of doxorubicin-induced cardiomyopathy. The gene discussed is ACE2; the disease is cardiomyopathy.